Posted 1 year, 5 months ago (0 comments)
Visit us on YouTube to view our new webinar: Graves' Disease, Thyroid Eye Disease and COVID-19 featuring Dr. Terry Smith and Dr. Don Kikkawa. (Approx. running time is 60 minutes).
Stuck at home? Connect with your fellow patients online! We have several formats available for online support, including oneGRAVESvoice (a collaboration between the GDATF, Horizon Therapeutics, and rareLife solutions), the GDATF's online support forum, and our closed Facebook group (click Join/Visit in the top right-hand corner of the screen). You can also contact a patient advocate at 877-643-3123 or [email protected]
Additional resources on COVID-19 that are specific to thyroid dysfunction and/or autoimmunity:
American Thyroid Association - Novel Coronavirus (COVID-19) and the Thyroid: Frequently Asked Questions
British Thyroid Foundation - Thyroid Disease and coronavirus (COVID-19)
The American Autoimmune Related Diseases Association has a number of resources (including recorded webinars) on their COVID-19 and Autoimmune Disease page.
In addition to your own state and county health departments, the following general resources will also hopefully be helpful:
Centers for Disease Control and Prevention (General Information)
Centers for Disease Control and Prevention - Stress and Coping
World Health Organization
Johns Hopkins Coronavirus Resource Center
Confused about the potential use of existing drugs as treatment options for COVID-19? This piece from the U.S. Food and Drug Administration explains the concept of "off-label" use and this article from the Centers for Disease Control lists potential therapeutic options for COVID-19. Use of these therapies must be supervised by a doctor; several deaths around the world have already occurred due to patients attempting to self-medicate.
The GDATF will continue to provide our community members with the latest information from credible sources. However, please be aware that this is a rapidly developing situation where guidance can change from day to day. Stay safe - and please check back for updates!